Thermo Fisher Scientific | TMO - Betriebsergebnis

Aktienkurs
496.12
Täglich Wechseln
-7.34 -1.46%
Monatlich
-2.72%
Jährlich
9.39%
Q2 Prognose
476.67




Betriebsergebnis Veränderung Datum
Abbott USD 2.25B 73M 2025-12
Agilent USD 353M 90M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 63.9M 13.2M 2025-09
Boston Scientific USD 1.24B 203M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
General Electric Aerospace USD 1.77B 536M 2025-12
Henry Schein USD 186M 12M 2025-12
Hologic USD 237M 16M 2025-12
Illumina USD 256M 6M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 15.3M 2025-12
Medtronic USD 1.74B 40M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
Olympus JPY 28B 5.56B 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quest Diagnostics USD 386M 0 2025-12
Repligen USD 19.97M 7.29M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Stryker USD 1.97B 609M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Veracyte USD 24.63M 1.52M 2025-12
Waters USD 270.52M 78.4M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12